Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

SOPs for Drug Discovery

SOP for Using Computational Tools for Target Pathway Analysis

Posted on By

The purpose of this Standard Operating Procedure (SOP) is to outline the use of computational tools in the analysis of target pathways during drug discovery. Understanding the molecular pathways and interactions involved in disease mechanisms is critical for identifying potential therapeutic targets. Computational tools can analyze biological networks, predict key molecular interactions, and help identify novel drug targets. This SOP ensures that computational tools are used systematically and effectively to support drug discovery by providing insights into target pathway analysis.
Click to read the full article.

Drug Discovery

SOP for Collaboration with CROs in Drug Discovery

Posted on By

The purpose of this Standard Operating Procedure (SOP) is to define the process for collaborating with Contract Research Organizations (CROs) in drug discovery. CROs provide specialized expertise and resources to support various stages of the drug discovery process, including preclinical research, clinical trials, and regulatory submissions. This SOP ensures that collaborations with CROs are conducted efficiently, with clear expectations and aligned goals, while maintaining quality and compliance with regulatory requirements.
Click to read the full article.

Drug Discovery

SOP for Early Stage Patent Analysis of Drug Candidates

Posted on By

The purpose of this Standard Operating Procedure (SOP) is to outline the process for conducting early-stage patent analysis of drug candidates during the drug discovery phase. Patent analysis helps identify the intellectual property landscape around a drug candidate, determine its patentability, and assess potential patent risks. This SOP ensures that patent analysis is conducted systematically, using reliable resources and methods to support decision-making in drug development.
Click to read the full article.

Drug Discovery

SOP for Knowledge Management in Drug Discovery Projects

Posted on By

The purpose of this Standard Operating Procedure (SOP) is to define the process for managing and sharing knowledge in drug discovery projects. Effective knowledge management ensures that valuable scientific data, research findings, intellectual property, and project insights are systematically captured, stored, and disseminated across teams. This SOP ensures that knowledge management practices are consistently followed, facilitating better decision-making and collaboration throughout the drug discovery process.
Click to read the full article.

Drug Discovery

SOP for Preparing and Submitting Drug Discovery Proposals

Posted on By

The purpose of this Standard Operating Procedure (SOP) is to outline the process for preparing and submitting drug discovery proposals within the drug development organization. These proposals are essential for securing funding, initiating new drug discovery projects, and establishing project timelines, budgets, and objectives. This SOP ensures that all drug discovery proposals are thoroughly prepared, scientifically sound, and aligned with organizational goals and regulatory requirements.
Click to read the full article.

Drug Discovery

SOP for Documentation and Record-Keeping in Drug Discovery

Posted on By

The purpose of this Standard Operating Procedure (SOP) is to establish the process for proper documentation and record-keeping throughout drug discovery projects. Accurate and thorough documentation is essential for regulatory compliance, maintaining data integrity, ensuring reproducibility, and facilitating effective communication among project teams. This SOP ensures that all data, protocols, experimental results, and project-related documents are consistently captured, stored, and accessible for future reference.
Click to read the full article.

Drug Discovery

SOP for Risk Assessment in Drug Discovery Projects

Posted on By

The purpose of this Standard Operating Procedure (SOP) is to outline the process for conducting risk assessment in drug discovery projects. Drug discovery is inherently associated with various scientific, regulatory, financial, and operational risks. This SOP aims to systematically identify, evaluate, and mitigate these risks to ensure the smooth progression of drug discovery and development efforts. The goal is to manage risks effectively, minimize their impact, and ensure that projects are completed on time, within budget, and in compliance with regulatory standards.
Click to read the full article.

Drug Discovery

SOP for Managing Multidisciplinary Teams in Drug Discovery Projects

Posted on By

The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for effectively managing multidisciplinary teams involved in drug discovery projects. Drug discovery requires expertise from various disciplines, including biology, chemistry, pharmacology, regulatory affairs, and data management. This SOP ensures that teams from different scientific backgrounds collaborate effectively, align their efforts toward common project goals, and ensure timely delivery of results while maintaining high standards of quality and compliance.
Click to read the full article.

Drug Discovery

SOP for Ethical Considerations in Drug Discovery Research

Posted on By

The purpose of this Standard Operating Procedure (SOP) is to outline the ethical considerations and principles that must be followed during drug discovery research. Ethical practices in drug discovery are essential for ensuring the safety, well-being, and rights of research participants, maintaining scientific integrity, and complying with regulatory and legal standards. This SOP provides guidelines for researchers to conduct their studies in an ethically responsible manner, ensuring that all experiments are carried out with the highest ethical standards.
Click to read the full article.

Drug Discovery

SOP for Handling and Disposal of Hazardous Chemicals in R&D

Posted on By

The purpose of this Standard Operating Procedure (SOP) is to outline the procedures for the safe handling, storage, and disposal of hazardous chemicals in research and development (R&D) activities. Ensuring the safety of personnel, compliance with regulatory requirements, and minimizing environmental impact are critical when working with hazardous chemicals. This SOP provides guidance to minimize the risks associated with chemical handling and waste disposal while promoting safe laboratory practices.
Click to read the full article.

Drug Discovery

Posts pagination

Previous 1 … 4 5 6 … 16 Next

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme